2022
Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview
Zhang C, Vermund S. Voluntary Medical Male Circumcision for HIV Prevention: a Global Overview. Current HIV/AIDS Reports 2022, 19: 474-483. PMID: 36348186, DOI: 10.1007/s11904-022-00632-y.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentCircumcision, MaleFemaleHIV InfectionsHomosexuality, MaleHumansMaleSexual and Gender MinoritiesSexual BehaviorConceptsVoluntary medical male circumcisionMedical male circumcisionHIV preventionMale circumcisionPrevention strategiesEvidence-based HIV prevention strategiesBehavioral prevention strategiesHigher sexual risk behaviorsHIV prevention strategiesSexual risk behaviorsPurpose of ReviewWithDecreased riskClinical trialsCircumcision coverageVMMC coverageProtective effectRecent FindingsThereHealth professionalsSystematic reviewIncidence areaRisk behaviorsSexual partnersHealth authoritiesHealth systemMale partners
2020
Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages
Bravo M, Peratikos MB, Muicha AS, Mahagaja E, Alvim MFS, Green AF, Wester CW, Vermund SH. Monitoring Pharmacy and Test Kit Stocks in Rural Mozambique: U.S. President's Emergency Plan for AIDS Relief Surveillance to Help Prevent Ministry of Health Shortages. AIDS Research And Human Retroviruses 2020, 36: 415-426. PMID: 31914787, PMCID: PMC7232670, DOI: 10.1089/aid.2019.0057.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsEpidemiological MonitoringHealth ServicesHumansMozambiquePharmaceutical PreparationsPharmacyReagent Kits, DiagnosticRural PopulationConceptsRural Zambézia ProvinceHuman immunodeficiency virusPresident's Emergency PlanMedication supplyU.S. President's Emergency PlanTimes higher oddsMedication classesViral suppressionDiagnostic test kitsImmunodeficiency virusPharmacy dataStudy midpointOrdinal logistic regressionHigher oddsCare providersLower oddsZambézia ProvinceTuberculosis testingMonitoring of drugsLogistic regressionAIDS ReliefHealth shortagesARVEmergency plansCalendar time
2016
Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial
Aliyu MH, Blevins M, Audet CM, Kalish M, Gebi UI, Onwujekwe O, Lindegren ML, Shepherd BE, Wester CW, Vermund SH. Integrated prevention of mother-to-child HIV transmission services, antiretroviral therapy initiation, and maternal and infant retention in care in rural north-central Nigeria: a cluster-randomised controlled trial. The Lancet HIV 2016, 3: e202-e211. PMID: 27126487, PMCID: PMC4852280, DOI: 10.1016/s2352-3018(16)00018-7.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdultAnti-HIV AgentsCD4 Lymphocyte CountDelivery of Health Care, IntegratedEarly Intervention, EducationalFamilyFemaleHIV InfectionsHumansInfantInfectious Disease Transmission, VerticalMaleMothersNevirapineNigeriaPregnancyPregnancy Complications, InfectiousPrenatal CareRural PopulationYoung AdultConceptsChild HIV transmissionAntiretroviral therapyStandard of careRural North-Central NigeriaWeeks post partumIntervention groupAntiretroviral prophylaxisEligible womenHIV statusHIV transmissionSecondary level health care facilitiesChild HIV transmission servicesClinical stage 1 diseasePost partumEunice Kennedy Shriver National InstituteMedian CD4 countPMTCT service deliveryAntiretroviral therapy initiationCD4 cell countPrevention of motherStage 1 diseaseUnknown HIV statusElimination of motherNorth Central NigeriaEarly infant diagnosis
2014
Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China
Lou J, Blevins M, Ruan Y, Vermund SH, Tang S, Webb GF, Shepherd BE, He X, Lu H, Shao Y, Qian HZ. Modeling the Impact on HIV Incidence of Combination Prevention Strategies among Men Who Have Sex with Men in Beijing, China. PLOS ONE 2014, 9: e90985. PMID: 24626165, PMCID: PMC3953201, DOI: 10.1371/journal.pone.0090985.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyHIV epidemicCondom useHIV prevalenceART coverageCombination prevention strategiesHIV/AIDSHIV testingHIV incidenceCombination interventionsBeijing MSMPrevention strategiesPrevalence estimatesPrevalenceEpidemic expansionMenInterventionEpidemicIncidenceBasic reproduction numberPrevention scenariosCurrent coverageSexReproduction numberIntervention levels
2013
Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a ‘Screen-And-Treat’ Program Integrated with HIV/AIDS Care in Zambia
Mwanahamuntu MH, Sahasrabuddhe VV, Blevins M, Kapambwe S, Shepherd BE, Chibwesha C, Pfaendler KS, Mkumba G, Vwalika B, Hicks ML, Vermund SH, Stringer JS, Parham GP. Utilization of Cervical Cancer Screening Services and Trends in Screening Positivity Rates in a ‘Screen-And-Treat’ Program Integrated with HIV/AIDS Care in Zambia. PLOS ONE 2013, 8: e74607. PMID: 24058599, PMCID: PMC3776830, DOI: 10.1371/journal.pone.0074607.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultDemographyEarly Detection of CancerFemaleHIV SeropositivityHumansLogistic ModelsMultivariate AnalysisProbabilityUterine Cervical NeoplasmsZambiaConceptsCervical cancer screening servicesCancer screening servicesHIV-seronegative womenHIV serostatusScreening servicesHIV/AIDS care programsCervical cancer prevention programsCervical cancer prevention servicesCervical cancer screening programsHIV/AIDS careHIV-seropositive womenCancer prevention servicesCancer prevention programsCancer screening programsAIDS care programsProportion of womenPatterns of utilizationHIV-seropositiveCervical cancerSaharan AfricaTest positivityPositivity rateAIDS careScreening programMultivariable modelingImpact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique
Shepherd BE, Blevins M, Vaz LM, Moon TD, Kipp AM, José E, Ferreira FG, Vermund SH. Impact of Definitions of Loss to Follow-up on Estimates of Retention, Disease Progression, and Mortality: Application to an HIV Program in Mozambique. American Journal Of Epidemiology 2013, 178: 819-828. PMID: 23785113, PMCID: PMC3755641, DOI: 10.1093/aje/kwt030.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusVisit scheduleKaplan-Meier techniqueRate of mortalityAntiretroviral therapyCumulative incidenceTreatment initiationEstimates of retentionImmunodeficiency syndromeImmunodeficiency virusHIV programsChronic diseasesDisease progressionPatient retentionImpact of definitionsHIV literatureClinical encountersStudy outcomesMortalityAIDSLTFDeathInformative censoringProgram evaluationStudy conclusions
2012
HIV/AIDS-Related Attitudes and Practices Among Traditional Healers in Zambézia Province, Mozambique
Audet CM, Blevins M, Moon TD, Sidat M, Shepherd BE, Pires P, Vergara A, Vermund SH. HIV/AIDS-Related Attitudes and Practices Among Traditional Healers in Zambézia Province, Mozambique. Journal Of Alternative And Complementary Medicine 2012, 18: 1133-1141. PMID: 23171035, PMCID: PMC3513988, DOI: 10.1089/acm.2011.0682.Peer-Reviewed Original ResearchConceptsZambézia ProvinceTraditional healersHuman immunodeficiency virus infection/HIV/AIDS careHealth systemAllopathic providersTreatment practicesAllopathic health systemSymptoms/signsHIV/AIDS-related attitudesPatient's symptoms/signsFormal health providersHIV/AIDS trainingHIV/AIDSHIV patientsHIV diseaseHIV pathogenesisImmunodeficiency syndromeUninfected personsInfection/Late presentationHIV trainingInfectious originHIV knowledgeReferral practicesTransitioning HIV care and treatment programs in southern Africa to full local management
Vermund SH, Sidat M, Weil LF, Tique JA, Moon TD, Ciampa PJ. Transitioning HIV care and treatment programs in southern Africa to full local management. AIDS 2012, 26: 1303-1310. PMID: 22706012, PMCID: PMC3576840, DOI: 10.1097/qad.0b013e3283552185.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsBotswanaDelivery of Health CareDeveloping CountriesDisease ManagementHIV InfectionsHumansMozambiqueSouth AfricaZambiaConceptsHIV careHIV/AIDS care programsAIDS ProgramPrimary health care systemUS President's Emergency PlanHealth care workersAIDS care programsHealth worker capacityHIV/AIDS programsPresident's Emergency PlanHealth care systemHIV programsAIDS careCare managementCare workersCare programTreatment programAIDS ReliefHealth care managementCare systemCarePrevention endeavorsEmergency plans
2011
Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a southeastern US clinic
Tamí‐Maury I, Willig J, Vermund S, Jolly P, Aban I, Hill J, Wilson CM. Contemporary profile of oral manifestations of HIV/AIDS and associated risk factors in a southeastern US clinic. Journal Of Public Health Dentistry 2011, 71: 257-264. PMID: 22320283, DOI: 10.1111/j.1752-7325.2011.00256.x.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAIDS-Related Opportunistic InfectionsAntiretroviral Therapy, Highly ActiveBlack or African AmericanCandidiasis, OralCD4 Lymphocyte CountCohort StudiesFemaleFollow-Up StudiesHeterosexualityHIV InfectionsHIV-1Homosexuality, MaleHumansMaleMouth DiseasesOropharynxPharyngeal DiseasesPrevalenceRetrospective StudiesRisk FactorsSex FactorsSoutheastern United StatesViral LoadYoung AdultConceptsOral manifestationsOropharyngeal candidiasisRisk factorsUS clinicsHIV-1 RNA viral loadLow baseline CD4 countBaseline CD4 valueMean baseline CD4Active antiretroviral therapyBaseline CD4 countRNA viral loadHIV-positive individualsHIV/AIDSLogistic regression modelsBaseline CD4Antiretroviral therapyCD4 countLaboratory characteristicsRetrospective reviewCD4 valuesViral loadHIV prevalenceMean ageT cellsHAARTAdvancing Cervical Cancer Prevention Initiatives in Resource-Constrained Settings: Insights from the Cervical Cancer Prevention Program in Zambia
Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP. Advancing Cervical Cancer Prevention Initiatives in Resource-Constrained Settings: Insights from the Cervical Cancer Prevention Program in Zambia. PLOS Medicine 2011, 8: e1001032. PMID: 21610859, PMCID: PMC3096609, DOI: 10.1371/journal.pmed.1001032.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeDeveloping CountriesFemaleHealth Plan ImplementationHealth ResourcesHealth Services AccessibilityHumansMedical InformaticsProgram EvaluationUterine Cervical NeoplasmsZambia
2010
Effect of treating co-infections on HIV-1 viral load: a systematic review
Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. The Lancet Infectious Diseases 2010, 10: 455-463. PMID: 20610327, PMCID: PMC3071714, DOI: 10.1016/s1473-3099(10)70093-1.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsCommunicable DiseasesHerpes SimplexHIV InfectionsHIV-1HumansMalariaParasitic DiseasesRNA, ViralSyphilisTuberculosisViral LoadConceptsViral load differencesViral loadPlasma HIV-1 RNA concentrationSystematic reviewMean plasma viral loadPlasma HIV RNA concentrationHIV-1 RNA concentrationsHIV-1 viral loadHIV RNA concentrationPlasma viral loadHIV transmission riskViral load reductionNon-pathogenic infectionsCo-infecting pathogensSyphilis treatmentHIV progressionTuberculosis treatmentEligible studiesPopulation-level benefitsTransmission riskLow-income countriesHIVTreatmentInfectionReview
2008
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression
Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008, 22: 2179-2185. PMID: 18832881, PMCID: PMC2661869, DOI: 10.1097/qad.0b013e328312c756.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeDisease ProgressionFemaleHeterosexualityHIV InfectionsHIV-1HumansMaleRisk AssessmentRNA, ViralViral LoadConceptsRisk of progressionHeterosexual transmissionDisease progressionHIV RNALog10 incrementAntiretroviral therapyPlasma HIV RNA levelsGreater riskTreatment of coinfectionHIV RNA levelsHIV viral loadViral load changesHIV-1 RNARelative risk estimatesHIV loadAdjunctive careViral loadPlasma levelsHeterosexual contactWorld's HIVAnnual riskHIVAdult populationViral transmissionRisk estimatesPrevention of mother-to-child HIV transmission and management of paediatric HIV infection in Jamaica.
Vermund SH, Krogstad PA. Prevention of mother-to-child HIV transmission and management of paediatric HIV infection in Jamaica. West Indian Medical Journal 2008, 57: 187-8. PMID: 19583116.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeFemaleHIV InfectionsHumansInfant, NewbornInfectious Disease Transmission, VerticalJamaicaPediatricsPregnancyPregnancy Complications, Infectious
2007
HIV Voluntary Counseling and Testing among Injection Drug Users in South China: A Study of a Non-Government Organization Based Program
Chen HT, Liang S, Liao Q, Wang S, Schumacher JE, Creger TN, Wilson CM, Dong B, Vermund SH. HIV Voluntary Counseling and Testing among Injection Drug Users in South China: A Study of a Non-Government Organization Based Program. AIDS And Behavior 2007, 11: 778-788. PMID: 17347877, DOI: 10.1007/s10461-007-9215-x.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultCatchment Area, HealthChinaCounselingCultureFemaleHIV SeropositivityHumansMaleMiddle AgedPrevalenceProgram DevelopmentPublic SectorSubstance Abuse, IntravenousVolitionConceptsHIV voluntary counselingVCT programmeVoluntary counselingDrug usersHIV prevention servicesHigh-risk populationInjection drug usersHIV prevalence ratesRapid HIVFemale IDUsHIV knowledgeSafe drugStudy populationGovernment health agenciesPrevalence ratesPrevention servicesSex practicesHealth agenciesIDUsRapid testVCTCounselingGreat needHIVPopulation
2006
Increasing AIDS case reports in the South: U.S. trends from 1981–2004
Qian HZ, Taylor RD, Fawal HJ, Vermund SH. Increasing AIDS case reports in the South: U.S. trends from 1981–2004. AIDS Care 2006, 18: 6-9. PMID: 16938669, DOI: 10.1080/09540120600839074.Peer-Reviewed Original ResearchAcquired Immunodeficiency SyndromeAdultFemaleHumansLinear ModelsMaleMiddle AgedPopulation SurveillancePuerto RicoUnited StatesUnited States Virgin IslandsMillions of Life-Years Saved with Potent Antiretroviral Drugs in the United States: A Celebration, with Challenges
Vermund SH. Millions of Life-Years Saved with Potent Antiretroviral Drugs in the United States: A Celebration, with Challenges. The Journal Of Infectious Diseases 2006, 194: 1-5. PMID: 16741874, DOI: 10.1086/505154.Peer-Reviewed Original ResearchAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsDelivery of Health CareDrug Therapy, CombinationHumansReverse Transcriptase InhibitorsTime FactorsUnited StatesHIV/AIDS in Pakistan: has the explosion begun?
Vermund SH, White H, Shah SA, Altaf A, Kristensen S, Khanani R, Mujeeb SA. HIV/AIDS in Pakistan: has the explosion begun? Journal Of The Pakistan Medical Association 2006, 56: s1-2. PMID: 16689472.Peer-Reviewed Original ResearchAcquired Immunodeficiency SyndromeGlobal HealthHIV SeropositivityHIV SeroprevalenceHumansPakistanPopulation SurveillanceRisk-Taking
2004
Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025
Wilson CM, Gray G, Read JS, Mwatha A, Lala S, Johnson S, Violari A, Sibiya PM, Fleming TR, Koonce A, Vermund SH, McIntyre J. Tolerance and Safety of Different Concentrations of Chlorhexidine for Peripartum Vaginal and Infant Washes: HIVNET 025. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2004, 35: 138-143. PMID: 14722445, PMCID: PMC2753236, DOI: 10.1097/00126334-200402010-00006.Peer-Reviewed Original ResearchConceptsChris Hani Baragwanath HospitalPrevention of motherHIV Type 1Solution of chlorhexidineConcentrations of chlorhexidineChild transmissionBaragwanath HospitalMaternal symptomsPrevention trialsThird trimesterClinical indicationsMaternity unitsSubjective complaintsVaginal areaWash groupType 1ChlorhexidineInfant examinationWomenSustainable interventionsTolerable concentrationInterventionMothersWashDifferent concentrations
2002
Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure
Skurnick JH, Palumbo P, DeVico A, Shacklett BL, Valentine FT, Merges M, Kamin-Lewis R, Mestecky J, Denny T, Lewis GK, Lloyd J, Praschunus R, Baker A, Nixon DF, Stranford S, Gallo R, Vermund SH, Louria DB. Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure. The Journal Of Infectious Diseases 2002, 185: 428-438. PMID: 11865394, PMCID: PMC2743095, DOI: 10.1086/338830.Peer-Reviewed Original ResearchConceptsSexual exposureSuppressive activityHuman immunodeficiency virus type 1 (HIV-1) infectionHigher CD8 cell countsHIV-1-suppressive activitySingle-cell cytokine productionHuman immunodeficiency virus type 1Macrophage inflammatory protein-1 betaVirus type 1 infectionHIV-positive male partnersInflammatory protein-1 betaMale partnersImmunodeficiency virus type 1CD4 cell responseCD8 cell countsHIV-positive donorsHIV-positive partnerHIV-negative partnersType 1 infectionInterferon-gamma secretionHIV-suppressive activityVirus type 1Apparent protective roleHIV antigenLocal antibodies
2001
Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study
Vermund SH. Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study. American Journal Of Epidemiology 2001, 153: 628-631. PMID: 11282788, DOI: 10.1093/aje/153.7.628.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAIDS VaccinesClinical Trials as TopicDisease OutbreaksFeasibility StudiesHIV InfectionsHumansPatient SelectionSensitivity and SpecificityUnited States